Clinica de Oncologie Sf Nectarie

Craiova 200542

2 studies enrolling now · 2 studies all time

What they study most

Colorectal Neoplasms, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer — Recruiting now